The Record

The Orders Library

Name: The COVID Project Orders Library
Creator: The COVID Project

13,511 instruments indexed by The COVID Project: the orders of the fifty States and the District, forty metros, the federal layer and the agencies; the standing duties; the organizers' notices; the legal authorities. Filter by kind, State, limitation type, quarter and more; open the exhibit; download what you find.

Double quotes make a phrase ("stay at home"). An exhibit ID (TX-004) opens its record first.

The COVID Projectcovidproject.com/library

Filters:Collection: Federal health, safety and transport layer Health care orders 2021 Q3 Clear all

25 instruments · showing 1–25

Sort Per page

Exhibit	Instrument	Issuer	Jurisdiction	Issued	Quarters	Limitations	Grade
Ex. FED-180	Declaration Under the PREP Act for Medical Countermeasures Against COVID-19, 85 Fed. Reg. 15198 (Mar. 17, 2020; effective Feb. 4, 2020)Declaration Under the Public Readiness and Emergency Preparedness Act for Medical Countermeasures Against COVID-19, 85 Fed. Reg. 15198 (Mar.…	Secretary of Health and Human Services	United StatesFederal	Mar. 10, 2020	2020 Q22020 Q32020 Q42021 Q12021 Q22021 Q3	Emergency declarationHealth care orders	Primary source read
Ex. FED-181	Determination of Public Health Emergency and Declaration that circumstances exist justifying the authorization of emergency use of in vitro diagnostics for 2019-nCoVDetermination of Public Health Emergency, 85 Fed. Reg. 7316 (Feb. 7, 2020)	Secretary of Health and Human Services	United StatesFederal	Feb. 4, 2020	2020 Q22020 Q32020 Q42021 Q12021 Q22021 Q3	Emergency declarationHealth care orders	Primary source read
Ex. FED-160	COVID-19 Emergency Declaration Blanket Waivers for Health Care Providers (consolidated document; version updated May 24, 2021)COVID-19 Emergency Declaration Blanket Waivers for Health Care Providers	Centers for Medicare & Medicaid Services, HHS	United States (Medicare, Medicaid and CHIP providers)Federal	Mar. 13, 2020	2020 Q22020 Q32020 Q42021 Q12021 Q22021 Q3	Health care ordersOther	Primary source read
Ex. FED-096	CMS QSO-20-13-Hospitals (Mar. 4, 2020), QSO-20-14-NH (Mar. 13, 2020), QSO-20-18-HHA (Mar. 10, 2020)QSO-20-13-Hospitals	CMS, Center for Clinical Standards and Quality / Quality, Safety & Oversight Group	United States (Medicare-participating hospitals)Federal	Mar. 4, 2020	2020 Q22020 Q32020 Q42021 Q12021 Q22021 Q3	Health care orders	Primary source read
Ex. FED-098	QSO-20-18-HHA, Guidance for Infection Control and Prevention Concerning Coronavirus Disease 2019 (COVID-19) in Home Health Agencies (HHAs)QSO-20-18-HHA	CMS, Quality, Safety & Oversight Group	United States (Medicare and Medicaid home health agencies)Federal	Mar. 10, 2020	2020 Q22020 Q32020 Q42021 Q12021 Q22021 Q3	Health care orders	Primary source read
Ex. FED-194	Notification of Enforcement Discretion for Telehealth Remote Communications During the COVID-19 Nationwide Public Health EmergencyNotification of Enforcement Discretion for Telehealth Remote Communications During the COVID-19 Nationwide Public Health Emergency, 85 Fed.…	HHS Office for Civil Rights	United States (HIPAA covered health care providers)Federal	Mar. 17, 2020	2020 Q22020 Q32020 Q42021 Q12021 Q22021 Q3	Health care ordersOther	Primary source read
Ex. FED-099	CMS QSO-20-12-All (Mar. 4, 2020), QSO-20-20-All (Mar. 23, 2020), QSO-20-31-All (June 1, 2020), QSO-20-35-ALL (Aug. 17, 2020)QSO-20-20-ALL, Prioritization of Survey Activities	CMS, Quality, Safety & Oversight Group	United States (all Medicare/Medicaid certified providers and suppliers; CLIA laboratories)Federal	Mar. 23, 2020	2020 Q22020 Q32020 Q42021 Q12021 Q22021 Q3	Health care ordersCourts and public offices	Primary source read
Ex. FED-184	Emergency Use Authorization Declaration: drugs and biological productsEmergency Use Authorization Declaration, 85 Fed. Reg. 18250 (Apr. 1, 2020)	Secretary of Health and Human Services	United StatesFederal	Mar. 27, 2020	2020 Q22020 Q32020 Q42021 Q12021 Q22021 Q3	Emergency declarationHealth care orders	Primary source read
Ex. FED-090	CMS-1744-IFC, Medicare and Medicaid Programs; Policy and Regulatory Revisions in Response to the COVID-19 Public Health Emergency (interim final rule with comment period)Medicare and Medicaid Programs; Policy and Regulatory Revisions in Response to the COVID-19 Public Health Emergency, 85 Fed. Reg. 19230…	Centers for Medicare & Medicaid Services, HHS	United States (Medicare and Medicaid providers)Federal	Mar. 30, 2020	2020 Q22020 Q32020 Q42021 Q12021 Q22021 Q3	Health care ordersOther	Primary source read
Ex. FED-091	CMS-5531-IFC, Additional Policy and Regulatory Revisions in Response to the COVID-19 Public Health Emergency (interim final rule)Medicare and Medicaid Programs, Basic Health Program, and Exchanges; Additional Policy and Regulatory Revisions in Response to the COVID-19…	Centers for Medicare & Medicaid Services, HHS	United StatesFederal	May 1, 2020	2020 Q22020 Q32020 Q42021 Q12021 Q22021 Q3	Health care ordersOther	Primary source read
Ex. FED-161	QSO-20-29-NH and CMS-5531-IFC, 85 Fed. Reg. 27550 (May 8, 2020): 42 C.F.R. 483.80(g) reportingQSO-20-29-NH	CMS, Quality, Safety & Oversight Group	United States (Medicare and Medicaid nursing homes)Federal	May 6, 2020	2020 Q22020 Q32020 Q42021 Q12021 Q22021 Q3	Health care ordersOther	Primary source read
Ex. FED-165	CMS QSO-20-12-All (Mar. 4, 2020), QSO-20-20-All (Mar. 23, 2020), QSO-20-31-All (June 1, 2020), QSO-20-35-ALL (Aug. 17, 2020)QSO-20-31-All (REVISED)	CMS, Quality, Safety & Oversight Group	United StatesFederal	June 1, 2020	2020 Q22020 Q32020 Q42021 Q12021 Q22021 Q3	Health care orders	Primary source read
Ex. FED-166	CMS QSO-20-12-All (Mar. 4, 2020), QSO-20-20-All (Mar. 23, 2020), QSO-20-31-All (June 1, 2020), QSO-20-35-ALL (Aug. 17, 2020)QSO-20-35-ALL	CMS, Quality, Safety & Oversight Group	United StatesFederal	Aug. 17, 2020	2020 Q32020 Q42021 Q12021 Q22021 Q3	Health care orders	Primary source read
Ex. FED-168	CMS-3401-IFC, 85 Fed. Reg. 54820 (Sept. 2, 2020) (42 C.F.R. 483.80(h) testing; 482.42(e) hospital reporting) and QSO-20-38-NH (Aug. 26, 2020; revised through Sept. 23, 2022)QSO-20-38-NH (Aug. 26, 2020)	CMS, Quality, Safety & Oversight Group	United States (Medicare and Medicaid LTC facilities)Federal	Aug. 26, 2020	2020 Q32020 Q42021 Q12021 Q22021 Q3	Health care ordersWorkplace rulesQuarantine and isolation	Primary source read
Ex. FED-092	CMS-3401-IFC, 85 Fed. Reg. 54820 (Sept. 2, 2020) (42 C.F.R. 483.80(h) testing; 482.42(e) hospital reporting) and QSO-20-38-NH (Aug. 26, 2020; revised through Sept. 23, 2022)Medicare and Medicaid Programs, Clinical Laboratory Improvement Amendments (CLIA), and Patient Protection and Affordable Care Act…	Centers for Medicare & Medicaid Services, HHS	United States (Medicare and Medicaid long-term care facilities; hospitals and CAHs; CLIA laboratories)Federal	Sept. 2, 2020	2020 Q32020 Q42021 Q12021 Q22021 Q3	Health care ordersWorkplace rulesQuarantine and isolation	Primary source read
Ex. FED-093	CMS-9912-IFC, Additional Policy and Regulatory Revisions in Response to the COVID-19 Public Health Emergency (interim final rule): 42 C.F.R. § 433.400 (FMAP maintenance-of-effort conditions); vaccine coverageAdditional Policy and Regulatory Revisions in Response to the COVID-19 Public Health Emergency, 85 Fed. Reg. 71142 (Nov. 6, 2020)	Centers for Medicare & Medicaid Services, HHS (with Treasury and Labor)	United States (State Medicaid programs; group health plans; providers)Federal	Nov. 2, 2020	2020 Q42021 Q12021 Q22021 Q3	Health care ordersOther	Primary source read
Ex. FED-185	Emergency Use Authorization letter: Pfizer-BioNTech COVID-19 Vaccine (Dec. 11, 2020; reissued and amended thereafter)Letter of Authorization, Pfizer-BioNTech COVID-19 Vaccine	Food and Drug Administration, HHS (Center for Biologics Evaluation and Research)	United StatesFederal	Dec. 11, 2020	2020 Q42021 Q12021 Q22021 Q3	Health care ordersOther	Primary source read
Ex. FED-186	Emergency Use Authorization letter: Moderna COVID-19 Vaccine (Dec. 18, 2020; reissued thereafter)Letter of Authorization, Moderna COVID-19 Vaccine	Food and Drug Administration, HHS	United StatesFederal	Dec. 18, 2020	2020 Q42021 Q12021 Q22021 Q3	Health care ordersOther	Primary source read
Ex. FED-187	Emergency Use Authorization letter: Janssen COVID-19 Vaccine (Feb. 27, 2021; reissued thereafter; revoked June 1, 2023)Letter of Authorization, Janssen COVID-19 Vaccine	Food and Drug Administration, HHS	United StatesFederal	Feb. 27, 2021	2021 Q12021 Q22021 Q3	Health care ordersOther	Primary source read
Ex. FED-156	QSO-20-39-NH REVISED Apr. 27, 2021, Nursing Home Visitation - COVID-19 (the text in force throughout 2021Q3)QSO-20-39-NH, Nursing Home Visitation - COVID-19 (REVISED 04/27/2021)	CMS, Quality, Safety & Oversight Group	United States (Medicare and Medicaid nursing homes)Federal	Apr. 27, 2021	2021 Q22021 Q3	Gathering capFace-covering requirementHealth care ordersWorkplace rulesQuarantine and isolation	Primary source read
Ex. FED-094	CMS-3414-IFC, 86 Fed. Reg. 26306 (May 13, 2021) (42 C.F.R. 483.80(d)(3)) and QSO-21-19-NHMedicare and Medicaid Programs; COVID-19 Vaccine Requirements for Long-Term Care (LTC) Facilities and Intermediate Care Facilities for…	Centers for Medicare & Medicaid Services, HHS	United States (Medicare and Medicaid LTC facilities and ICFs-IID)Federal	May 13, 2021	2021 Q22021 Q3	Health care ordersWorkplace rulesVaccination or testing	Primary source read
Ex. FED-163	CMS-3414-IFC, 86 Fed. Reg. 26306 (May 13, 2021) (42 C.F.R. 483.80(d)(3)) and QSO-21-19-NHQSO-21-19-NH	CMS, Quality, Safety & Oversight Group	United States (Medicare and Medicaid LTC facilities)Federal	May 11, 2021	2021 Q22021 Q3	Health care ordersWorkplace rulesVaccination or testing	Primary source read
Ex. FED-080	Occupational Exposure to COVID-19; Emergency Temporary Standard, 29 C.F.R. 1910.502, 86 Fed. Reg. 32376 (June 21, 2021)Occupational Exposure to COVID-19; Emergency Temporary Standard, 86 Fed. Reg. 32376 (June 21, 2021)	Occupational Safety and Health Administration, U.S. Department of Labor	United States (every setting 'where any employee provides healthcare services or healthcare support services'; federal OSHA States directly, State-plan States through adoption within 30 days)Federal	June 21, 2021	2021 Q22021 Q3	Capacity limitFace-covering requirementHealth care ordersWorkplace rulesVaccination or testingQuarantine and isolation	Primary source read
Ex. FED-081	DIR 2021-02 (CPL 02), Inspection Procedures for the COVID-19 ETS (June 28, 2021)DIR 2021-02 (CPL 02), Inspection Procedures for the COVID-19 Emergency Temporary Standard	OSHA, Directorate of Enforcement Programs	United States (OSHA-wide)Federal	June 28, 2021	2021 Q22021 Q3	Health care ordersWorkplace rules	Primary source read
Ex. FED-083	DIR 2021-03 (CPL 03), Revised National Emphasis Program - COVID-19 (July 7, 2021)DIR 2021-03 (CPL 03), Revised National Emphasis Program - Coronavirus Disease 2019 (COVID-19)	OSHA, Directorate of Enforcement Programs	United States (OSHA-wide)Federal	July 7, 2021	2021 Q3	Health care ordersWorkplace rules	Primary source read

Secretary of Health and Human Services, Declaration Under the PREP Act for Medical Countermeasures Against COVID-19, 85 Fed. Reg. 15198 (Mar. 17, 2020; effective Feb. 4, 2020) (Mar. 10, 2020) (Ex. FED-180)
Secretary of Health and Human Services, Determination of Public Health Emergency and Declaration that circumstances exist justifying the authorization of emergency use of in vitro diagnostics for 2019-nCoV (Feb. 4, 2020) (Ex. FED-181)
Centers for Medicare & Medicaid Services, HHS, COVID-19 Emergency Declaration Blanket Waivers for Health Care Providers (consolidated document; version updated May 24, 2021) (Mar. 13, 2020) (Ex. FED-160)
CMS, Center for Clinical Standards and Quality / Quality, Safety & Oversight Group, CMS QSO-20-13-Hospitals (Mar. 4, 2020), QSO-20-14-NH (Mar. 13, 2020), QSO-20-18-HHA (Mar. 10, 2020) (Ex. FED-096)
CMS, Quality, Safety & Oversight Group, QSO-20-18-HHA, Guidance for Infection Control and Prevention Concerning Coronavirus Disease 2019 (COVID-19) in Home Health Agencies (HHAs) (Mar. 10, 2020) (Ex. FED-098)
HHS Office for Civil Rights, Notification of Enforcement Discretion for Telehealth Remote Communications During the COVID-19 Nationwide Public Health Emergency (Mar. 17, 2020) (Ex. FED-194)
CMS, Quality, Safety & Oversight Group, CMS QSO-20-12-All (Mar. 4, 2020), QSO-20-20-All (Mar. 23, 2020), QSO-20-31-All (June 1, 2020), QSO-20-35-ALL (Aug. 17, 2020) (Ex. FED-099)
Secretary of Health and Human Services, Emergency Use Authorization Declaration: drugs and biological products (Mar. 27, 2020) (Ex. FED-184)
Centers for Medicare & Medicaid Services, HHS, CMS-1744-IFC, Medicare and Medicaid Programs; Policy and Regulatory Revisions in Response to the COVID-19 Public Health Emergency (interim final rule with comment period) (Mar. 30, 2020) (Ex. FED-090)
Centers for Medicare & Medicaid Services, HHS, CMS-5531-IFC, Additional Policy and Regulatory Revisions in Response to the COVID-19 Public Health Emergency (interim final rule) (May 1, 2020) (Ex. FED-091)
CMS, Quality, Safety & Oversight Group, QSO-20-29-NH and CMS-5531-IFC, 85 Fed. Reg. 27550 (May 8, 2020): 42 C.F.R. 483.80(g) reporting (May 6, 2020) (Ex. FED-161)
CMS, Quality, Safety & Oversight Group, CMS QSO-20-12-All (Mar. 4, 2020), QSO-20-20-All (Mar. 23, 2020), QSO-20-31-All (June 1, 2020), QSO-20-35-ALL (Aug. 17, 2020) (Ex. FED-165)
CMS, Quality, Safety & Oversight Group, CMS QSO-20-12-All (Mar. 4, 2020), QSO-20-20-All (Mar. 23, 2020), QSO-20-31-All (June 1, 2020), QSO-20-35-ALL (Aug. 17, 2020) (Ex. FED-166)
CMS, Quality, Safety & Oversight Group, CMS-3401-IFC, 85 Fed. Reg. 54820 (Sept. 2, 2020) (42 C.F.R. 483.80(h) testing; 482.42(e) hospital reporting) and QSO-20-38-NH (Aug. 26, 2020; revised through Sept. 23, 2022) (Ex. FED-168)
Centers for Medicare & Medicaid Services, HHS, CMS-3401-IFC, 85 Fed. Reg. 54820 (Sept. 2, 2020) (42 C.F.R. 483.80(h) testing; 482.42(e) hospital reporting) and QSO-20-38-NH (Aug. 26, 2020; revised through Sept. 23, 2022) (Ex. FED-092)
Centers for Medicare & Medicaid Services, HHS (with Treasury and Labor), CMS-9912-IFC, Additional Policy and Regulatory Revisions in Response to the COVID-19 Public Health Emergency (interim final rule): 42 C.F.R. § 433.400 (FMAP maintenance-of-effort conditions); vaccine coverage (Nov. 2, 2020) (Ex. FED-093)
Food and Drug Administration, HHS (Center for Biologics Evaluation and Research), Emergency Use Authorization letter: Pfizer-BioNTech COVID-19 Vaccine (Dec. 11, 2020; reissued and amended thereafter) (Ex. FED-185)
Food and Drug Administration, HHS, Emergency Use Authorization letter: Moderna COVID-19 Vaccine (Dec. 18, 2020; reissued thereafter) (Ex. FED-186)
Food and Drug Administration, HHS, Emergency Use Authorization letter: Janssen COVID-19 Vaccine (Feb. 27, 2021; reissued thereafter; revoked June 1, 2023) (Ex. FED-187)
CMS, Quality, Safety & Oversight Group, QSO-20-39-NH REVISED Apr. 27, 2021, Nursing Home Visitation - COVID-19 (the text in force throughout 2021Q3) (Ex. FED-156)
Centers for Medicare & Medicaid Services, HHS, CMS-3414-IFC, 86 Fed. Reg. 26306 (May 13, 2021) (42 C.F.R. 483.80(d)(3)) and QSO-21-19-NH (Ex. FED-094)
CMS, Quality, Safety & Oversight Group, CMS-3414-IFC, 86 Fed. Reg. 26306 (May 13, 2021) (42 C.F.R. 483.80(d)(3)) and QSO-21-19-NH (May 11, 2021) (Ex. FED-163)
Occupational Safety and Health Administration, U.S. Department of Labor, Occupational Exposure to COVID-19; Emergency Temporary Standard, 29 C.F.R. 1910.502, 86 Fed. Reg. 32376 (June 21, 2021) (Ex. FED-080)
OSHA, Directorate of Enforcement Programs, DIR 2021-02 (CPL 02), Inspection Procedures for the COVID-19 ETS (June 28, 2021) (Ex. FED-081)
OSHA, Directorate of Enforcement Programs, DIR 2021-03 (CPL 03), Revised National Emphasis Program - COVID-19 (July 7, 2021) (Ex. FED-083)

The Orders Library

Results